Bob Klein, will continue as the chairman of the oversight board for up to 6 months Read more…
Calling the process of selecting a chairman for the state’s $3B stem cell research funding agency “fundamentally flawed,” Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.